The retention and elimination of fluorine in bones.

G. Glock,F. Lowater,M. Murray

DOI: https://doi.org/10.1042/BJ0351235

IF: 3.766

1941-11-01

Biochemical Journal

Abstract:

What problem does this paper attempt to address?

Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls And Predict Early Alzheimer'S Disease Via Untargeted Lipidomics Analysis

Lumi Zhang,Lingxiao Li,Fanxia Meng,Jie Yu,Fangping He,Yajie Lin,Yujie Su,Mengjie Hu,Xiaoyan Liu,Yang Liu,Benyan Luo,Guoping Peng

DOI: https://doi.org/10.3389/fneur.2021.704582

IF: 3.4

2021-01-01

Frontiers in Neurology

Abstract:Background and Aim: Alzheimer's disease (AD) is the most common type of dementia and presents with metabolic perturbations early in the disease process. In order to explore biomarkers useful in predicting early AD, we compared serum metabolites among patients suffering different stages of AD.Methods: We recruited 107 participants including 23 healthy controls (HC), 21 amnestic mild cognitive impairment (aMCI), 24 non-amnestic mild cognitive impairment (naMCI) and 39 AD patients. Via liquid chromatography-mass spectrometry based serum untargeted lipidomics analysis, we compared differences in serum lipid metabolites among these patient groups and further elucidated biomarkers that differentiate aMCI from HC.Results: There were significant differences of serum lipid metabolites among the groups, and 20 metabolites were obtained under negative ion mode from HC and aMCI comparison. Notably, 16:3 cholesteryl ester, ganglioside GM3 (d18:1/9z-18:1) and neuromedin B were associated with cognition and increased the predictive effect of aMCI to 0.98 as revealed by random forest classifier. The prediction model composed of MoCA score, 16:3 cholesteryl ester and ganglioside GM3 (d18:1/9z-18:1) had good predictive performance for aMCI. Glycerophospholipid metabolism was a pathway common among HC/aMCI and aMCI/AD groups.Conclusion: This study provides preliminary evidence highlighting that 16:3 cholesteryl ester were useful for AD disease monitoring while ganglioside GM3 (d18:1/9z-18:1) and neuromedin B discriminated aMCI from HC, which can probably be applied in clinic for early predicting of AD.
Largescale Multicenter Study of a Serum Metabolite Biomarker Panel for the Diagnosis of Breast Cancer

Yanzhong Wang,Rui An,Haitao Yu,Yuehong Dai,Luping Lou,Sheng Quan,Rongchang Chen,Yanjun Ding,Hongcan Zhao,Xuanlan Wu,Zhen Liu,Qinchuan Wang,Yuzhen Gao,Xinyou Xie,Jun Zhang

DOI: https://doi.org/10.1016/j.isci.2024.110345

IF: 5.8

2024-01-01

iScience

Abstract:Breast cancer (BC) is currently the most prevalent malignancy worldwide, and finding effective non-invasive biomarkers for routine clinical detection of BC remains a significant challenge. Here, we performed non-targeted and targeted metabolomics analysis on the screening, training and validation cohorts of serum samples from 1,947 participants. A metabolite biomarker model including glutamate, erythronate, docosahexaenoate, propionylcarnitine, and patient’s age was established for detecting BC. This model demonstrated better diagnostic performance than carbohydrate antigen 15-3 (CA15-3) and carcinoembryonic antigen (CEA) alone in discriminating BC from healthy controls both in the training and validation cohorts [area under the curve (AUC), 0.954; sensitivity, 87.1% and specificity, 93.5% for the training cohort and 0.834, 68.3%, and 85.2%, respectively, for the validation cohort 1]. This study has established a noninvasive approach for the detection of BC, which shows potential as a suitable supplement to the clinical screening methods currently employed for BC.
Metabolomics in Age-Related Macular Degeneration: A Systematic Review

Xiao-Wen Hou,Ying Wang,Chen-Wei Pan

DOI: https://doi.org/10.1167/iovs.61.14.13

2020-12-14

Investigative Opthalmology and Visual Science

Abstract:Age-related macular degeneration (AMD) is one of the leading causes of blindness among the elderly, and the exact pathogenesis of the AMD remains unclear. The purpose of this review is to summarize potential metabolic biomarkers and pathways of AMD that might facilitate risk predictions and clinical diagnoses of AMD.We obtained relevant publications of metabolomics studies of human beings by systematically searching the MEDLINE (PubMed) database before June 2020. Studies were included if they performed mass spectrometry-based or nuclear magnetic resonance-based metabolomics approach for humans. In addition, AMD was assessed from fundus photographs based on standardized protocols. The metabolic pathway analysis was performed using MetaboAnalyst 3.0.Thirteen studies were included in this review. Repeatedly identified metabolites including phenylalanine, adenosine, hypoxanthine, tyrosine, creatine, citrate, carnitine, proline, and maltose have the possibility of being biomarkers of AMD. Validation of the biomarker panels was observed in one study. Dysregulation of metabolic pathways involves lipid metabolism, carbohydrate metabolism, nucleotide metabolism, amino acid metabolism, and translation, which might play important roles in the development and progression of AMD.This review summarizes the potential metabolic biomarkers and pathways related to AMD, providing opportunities for the construction of diagnostic or predictive models for AMD and the discovery of new therapeutic targets.
Untargeted Metabolomics for Uncovering Plasma Biological Markers of Wet Age-Related Macular Degeneration.

Yanhui Deng,Ping Shuai,Haixin Wang,Shanshan Zhang,Jie Li,Mingyan Du,Peirong Huang,Chao Qu,Lulin Huang

DOI: https://doi.org/10.18632/aging.203006

2021-01-01

Aging

Abstract:Wet age-related macular degeneration (wAMD) causes central vision loss and represents a major health problem in elderly people. Here we have used untargeted metabolomics using UHPLC-MS to profile plasma from 127 patients with wAMD (67 choroidal neovascularization (CNV) and 60 polypoidal choroidal vasculopathy (PCV)) and 50 controls. A total of 545 biochemicals were detected. Among them, 17 metabolites presented difference between patients with wAMD and controls. Most of them were oxidized lipids (N=6, 35.29%). Comparing to controls, 28 and 18 differential metabolites were identified in patients with CNV and PCV, respectively. Two metabolites, hyodeoxycholic acid and L-tryptophanamide, were differently distributed between PCV and CNV. We first investigated the genetic association with metabolites in wet AMD (CFH rs800292 and HTRA1 rs10490924). We identified six differential metabolites between the GG and AA genotypes of CFH rs800292, five differential metabolites between the GG and AA genotypes of HTRA1 rs10490924, and four differential metabolites between the GG and GA genotypes of rs10490924. We selected four metabolites (cyclamic acid, hyodeoxycholic acid, L-tryptophanamide and O-phosphorylethanolamine) for in vitro experiments. Among them, cyclamic acid reduced the activity, inhibited the proliferation, increased the apoptosis and necrosis in human retinal pigment epithelial cells (HRPECs). L-tryptophanamide affected the proliferation, apoptosis and necrosis in HRPECs, and promoted the tube formation and migration in primary human retinal endothelial cells (HRECs). Hyodeoxycholic acid and O-phosphorylethanolamine inhibited the tube formation and migration in HRECs. The results suggested that differential metabolites have certain effects on wAMD pathogenesis-related HRPECs and HRECs.
Alterations in Faecal and Serum Metabolic Profiles in Patients with Neovascular Age-Related Macular Degeneration.

Qixian Yuan,Shuai Zhu,Siqing Yue,Yuqiu Han,Guoping Peng,Lanjuan Li,Yan Sheng,Baohong Wang

DOI: https://doi.org/10.3390/nu15132984

IF: 5.9

2023-01-01

Nutrients

Abstract:Neovascular age-related macular degeneration (nAMD) is a common and multifactorial disease in the elderly that may lead to irreversible vision loss; yet the pathogenesis of AMD remains unclear. In this study, nontargeted metabolomics profiling using ultra-performance liquid chromatography coupled with Q-Exactive Orbitrap mass spectrometry was applied to discover the metabolic feature differences in both faeces and serum samples between Chinese nonobese subjects with and without nAMD. In faecal samples, a total of 18 metabolites were significantly altered in nAMD patients, and metabolic dysregulations were prominently involved in glycerolipid metabolism and nicotinate and nicotinamide metabolism. In serum samples, a total of 29 differential metabolites were founded, involved in caffeine metabolism, biosynthesis of unsaturated fatty acids, and purine metabolism. Two faecal metabolites (palmitoyl ethanolamide and uridine) and three serum metabolites (4-hydroxybenzoic acid, adrenic acid, and palmitic acid) were selected as potential biomarkers for nAMD. Additionally, the significant correlations among dysregulated neuroprotective, antineuroinflammatory, or fatty acid metabolites in faecal and serum and IM dysbiosis were found. This comprehensive metabolomics study of faeces and serum samples showed that alterations in IM-mediated neuroprotective metabolites may be involved in the pathophysiology of AMD, offering IM-based nutritional therapeutic targets for nAMD.
Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration

Tantai Zhao,Jiani Li,Yanbin Wang,Xiaojian Guo,Yun Sun

DOI: https://doi.org/10.1016/j.heliyon.2023.e20329

IF: 3.776

2023-09-21

Heliyon

Abstract:Age-related macular degeneration (AMD) causes irreversible vision-loss among the elderly in industrial countries. Neovascular AMD (nAMD), which refers to late-stage AMD, is characterized by severe vision-threatening choroidal neovascularization (CNV). Herein, we constructed a global metabolic network of nAMD, based on untargeted metabolomic and lipidomic analysis of plasma samples collected from sixty subjects (30 nAMD patients and 30 age-matched controls). Among the nAMD and control groups, 62 and 44 significantly different metabolites were detected in the positive and negative ion modes, respectively. Grouping analysis further showed that lipid and lipid-like molecule-based superclasses contained the highest number of significantly different metabolites. Lipidomic analysis revealed that 53 lipids among the nAMD and control groups differed significantly; these belonged to four major lipid categories (glycerophospholipids, sphingolipids, glycerolipids, and fatty acids). A discriminative biomarker panel comprising 16 metabolites and lipids, which was constructed using multivariate statistical machine learning methods, could effectively identify nAMD cases. Among these 16 compounds, eight were lipids that belonged to three lipid categories (glycerophospholipids, sphingolipids, and prenol lipids). The top three biomarkers with the highest importance scores were all lipids (a glycerophospholipid and two sphingolipids), highlighting the crucial role played by glycerophospholipid and sphingolipid pathways in nAMD. These differences between the metabolic and lipid profiles of nAMD patients and elderly individuals without AMD provide a readout of the overall metabolic status of nAMD. Further insights into the identified discriminative biomarkers may pave the way for future diagnostic and therapeutic interventions for nAMD.
Olink Profiling of Aqueous Humor Identifies Novel Biomarkers for Wet Age-Related Macular Degeneration.

Qing Liu,Hui-Ying Zhang,Qiu-Yang Zhang,Feng-Sheng Wang,Yue Zhu,Si-Guo Feng,Qin Jiang,Biao Yan

DOI: https://doi.org/10.1021/acs.jproteome.4c00195

2024-01-01

Journal of Proteome Research

Abstract:Metabolic dysfunction is recognized as a contributing factor in the pathogenesis of wet age-related macular degeneration (wAMD). However, the specific metabolism-related proteins implicated in wAMD remain elusive. In this study, we assessed the expression profiles of 92 metabolism-related proteins in aqueous humor (AH) samples obtained from 44 wAMD patients and 44 cataract control patients. Our findings revealed significant alterations in the expression of 60 metabolism-related proteins between the two groups. Notably, ANGPTL7 and METRNL displayed promising diagnostic potential for wAMD, as evidenced by area under the curve values of 0.88 and 0.85, respectively. Subsequent validation studies confirmed the upregulation of ANGPTL7 and METRNL in the AH of wAMD patients and in choroidal neovascularization (CNV) models. Functional assays revealed that increased ANGPTL7 and METRNL played a pro-angiogenic role in endothelial biology by promoting endothelial cell proliferation, migration, tube formation, and spouting in vitro. Moreover, in vivo studies revealed the pro-angiogenic effects of ANGPTL7 and METRNL in CNV formation. In conclusion, our findings highlight the association between elevated ANGPTL7 and METRNL levels and wAMD, suggesting their potential as novel predictive and diagnostic biomarkers for this condition. These results underscore the significance of ANGPTL7 and METRNL in the context of wAMD pathogenesis and offer new avenues for future research and therapeutic interventions.
Multiomic Screening Unravels the Immunometabolic Signatures and Drug Targets of Age-Related Macular Degeneration

Xuehao Cui,Qiuchen Zhao,Bidesh Mahata,Dejia Wen,Patrick Yu-Wai-Man,Xiaorong Li

DOI: https://doi.org/10.1101/2024.05.07.592898

2024-05-10

Abstract:Age-related macular degeneration (AMD) is a significant cause of visual impairment in the aging population, with the pathophysiology driven by a complex interplay of genetics, environmental influences and immunometabolic factors. These immunometabolic mechanisms, in particular, those distinguishing between the dry and wet forms of AMD, remain incompletely understood. Utilizing an integrated multiomic approach, incorporating Mendelian Randomization (MR) and single-cell RNA sequencing (scRNA-seq), we have effectively delineated distinct immunometabolic pathways implicated in the development of AMD. Our comprehensive analysis indicates that the androgen-IL10RA-CD16+ monocyte axis could protect against wet AMD. We have also identified several immune and metabolic signatures unique to each AMD subtype, with TNFα and Notch signaling pathways being central to disease progression. Furthermore, our analysis, leveraging expression Quantitative Trait Loci (eQTLs) from the Genotype-Tissue Expression (GTEx) project coupled with MR, have highlighted genes such as , , , , and as prospective therapeutic targets. The therapeutic potential of these candidate genes was validated with observations from existing drug trial databases. Our robust genetic and transcriptomic approach has identified promising directions for novel AMD interventions, emphasizing the significance of an integrated multiomic approach in tackling this important cause of visual impairment.

Immunology
Choroidal biomarkers in age-related macular degeneration

Elham Sadeghi,Nicola Valsecchi,Elham Rahmanipour,Mahsa Ejlalidiz,Nasiq Hasan,Kiran Kumar Vupparaboina,Mohammed Nasar Ibrahim,Mohammed Abdul Rasheed,Jiwon Baek,Danilo Iannetta,Jay Chhablani

DOI: https://doi.org/10.1016/j.survophthal.2024.10.004

2024-10-18

Abstract:Age-related macular degeneration (AMD) is the leading cause of central visual impairment in the elderly. The exact pathophysiological mechanisms for AMD remain uncertain. Several studies suggest that choroidal abnormalities and alterations are critical in AMD progression. The transition from manual to automated segmentation and binarization techniques has resulted in accurate and precise measurements of different choroidal parameters. These qualitative and quantitative parameters, known as choroidal imaging biomarkers, have advanced from basic vertical subfoveal choroidal thickness to more intricate 3-dimensional choroidal reconstruction methods in the last decade. Therefore, a comprehensive evaluation of choroidal metrics may investigate valuable insights into AMD, potentially guiding the future development of customized therapeutic strategies and personalized patient care in AMD management. We describe the role of different choroidal biomarkers in evaluating patients with AMD and their contribution to management.
Transfer of spectral weight in an exactly solvable model of strongly correlated electrons in infinite dimensions.

Möller,Ruckenstein,Schmitt-Rink

DOI: https://doi.org/10.1103/PHYSREVB.46.7427

1992-09-15

Abstract:We study the simplest nontrivial model that describes a basic feature of strongly correlated systems, namely, the transfer of spectral weight between high- and low-energy excitations. We use the limit of infinite dimensions to calculate exactly the corresponding single-particle and optical-conductivity spectra. We comment on the relevance of these results to a recently proposed scenario for the breakdown of Fermi-liquid theory in strongly correlated metals.
A Collaborative Approach to Teaching Medical Students how to Screen, Intervene, and Treat Substance Use Disorders

K. Neufeld,A. Alvanzo,V. King,L. Feldman,Jeffrey H. Hsu,D. Rastegar,Jorie M. Colbert,D. MacKinnon

DOI: https://doi.org/10.1080/08897077.2011.640090

2012-06-27

Substance Abuse

Abstract:Few medical schools require a stand-alone course to develop knowledge and skills relevant to substance use disorders (SUDs). The authors successfully initiated a new course for second-year medical students that used screening, brief intervention, and referral to treatment (SBIRT) as the course foundation. The 15-hour course (39 faculty teaching hours) arose from collaboration between faculty in Departments of Medicine and Psychiatry and included 5 hours of direct patient interaction during clinical demonstrations and in small-group skills development. Pre- and post-exam results suggest that the course had a significant impact on knowledge about SUDs. The authors’ experience demonstrates that collaboration between 2 clinical departments can produce a successful second-year medical student course based in SBIRT principles.
Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia

Gizachew Tilahun Belete,Lei Zhou,King-Kit Li,Pui-Kin So,Chi-Wai Do,Thomas Chuen Lam

DOI: https://doi.org/10.3389/fmolb.2024.1403844

2024-08-13

Abstract:Introduction: Multifactorial Eye disorders are a significant public health concern and have a huge impact on quality of life. The pathophysiological mechanisms underlying these eye disorders were not completely understood since functional and low-throughput biological tests were used. By identifying biomarkers linked to eye disorders, metabolomics enables early identification, tracking of the course of the disease, and personalized treatment. Methods: The electronic databases of PubMed, Scopus, PsycINFO, and Web of Science were searched for research related to Age-Related macular degeneration (AMD), glaucoma, myopia, and diabetic retinopathy (DR). The search was conducted in August 2023. The number of cases and controls, the study's design, the analytical methods used, and the results of the metabolomics analysis were all extracted. Using the QUADOMICS tool, the quality of the studies included was evaluated, and metabolic pathways were examined for distinct metabolic profiles. We used MetaboAnalyst 5.0 to undertake pathway analysis of differential metabolites. Results: Metabolomics studies included in this review consisted of 36 human studies (5 Age-related macular degeneration, 10 Glaucoma, 13 Diabetic retinopathy, and 8 Myopia). The most networked metabolites in AMD include glycine and adenosine monophosphate, while methionine, lysine, alanine, glyoxylic acid, and cysteine were identified in glaucoma. Furthermore, in myopia, glycerol, glutamic acid, pyruvic acid, glycine, cysteine, and oxoglutaric acid constituted significant metabolites, while glycerol, glutamic acid, lysine, citric acid, alanine, and serotonin are highly networked metabolites in cases of diabetic retinopathy. The common top metabolic pathways significantly enriched and associated with AMD, glaucoma, DR, and myopia were arginine and proline metabolism, methionine metabolism, glycine and serine metabolism, urea cycle metabolism, and purine metabolism. Conclusion: This review recapitulates potential metabolic biomarkers, networks and pathways in AMD, glaucoma, DR, and myopia, providing new clues to elucidate disease mechanisms and therapeutic targets. The emergence of advanced metabolomics techniques has significantly enhanced the capability of metabolic profiling and provides novel perspectives on the metabolism and underlying pathogenesis of these multifactorial eye conditions. The advancement of metabolomics is anticipated to foster a deeper comprehension of disease etiology, facilitate the identification of novel therapeutic targets, and usher in an era of personalized medicine in eye research.
A proteogenomic signature of age-related macular degeneration in blood

Valur Emilsson,Elias F. Gudmundsson,Thorarinn Jonmundsson,Brynjolfur G. Jonsson,Michael Twarog,Valborg Gudmundsdottir,Zhiguang Li,Nancy Finkel,Stephen Poor,Xin Liu,Robert Esterberg,Yiyun Zhang,Sandra Jose,Chia-Ling Huang,Sha-Mei Liao,Joseph Loureiro,Qin Zhang,Cynthia L. Grosskreutz,Andrew A. Nguyen,Qian Huang,Barrett Leehy,Rebecca Pitts,Thor Aspelund,John R. Lamb,Fridbert Jonasson,Lenore J. Launer,Mary Frances Cotch,Lori L. Jennings,Vilmundur Gudnason,Tony E. Walshe

DOI: https://doi.org/10.1038/s41467-022-31085-x

IF: 16.6

2022-06-13

Nature Communications

Abstract:Abstract Age-related macular degeneration (AMD) is one of the most common causes of visual impairment in the elderly, with a complex and still poorly understood etiology. Whole-genome association studies have discovered 34 genomic regions associated with AMD. However, the genes and cognate proteins that mediate the risk, are largely unknown. In the current study, we integrate levels of 4782 human serum proteins with all genetic risk loci for AMD in a large population-based study of the elderly, revealing many proteins and pathways linked to the disease. Serum proteins are also found to reflect AMD severity independent of genetics and predict progression from early to advanced AMD after five years in this population. A two-sample Mendelian randomization study identifies several proteins that are causally related to the disease and are directionally consistent with the observational estimates. In this work, we present a robust and unique framework for elucidating the pathobiology of AMD.

multidisciplinary sciences
Causal influence of plasma metabolites on age-related macular degeneration: A Mendelian randomization study

Tao Wang,Chun Huang,Jinshuai Li,Xiangjian Wu,Xiaoyan Fu,Yimin Hu,Geping Wu,Chunfeng Yang,Sheng Chen

DOI: https://doi.org/10.1097/MD.0000000000039400

2024-09-13

Abstract:Using genome-wide association study data from European populations, this research clarifies the causal relationship between plasma metabolites and age-related macular degeneration (AMD) and employs Metabo Analyst 5.0 for enrichment analysis to investigate their metabolic pathways. Employing Mendelian randomization analysis, this study leveraged single nucleotide polymorphisms significantly associated with plasma metabolites as instrumental variables. This approach established a causal link between metabolites and AMD. Analytical methods such as inverse-variance weighted, Mendelian randomization-Egger, and weighted median were applied to validate causality. Mendelian Randomization Pleiotropy Residual Sum and Outlier was utilized for outlier detection and correction, and Cochran's Q test was conducted to assess heterogeneity. To delve deeper into the metabolic characteristics of AMD, metabolic enrichment analysis was performed using Metabo Analyst 5.0. These combined methods provided a robust framework for elucidating the metabolic underpinnings of AMD. The 2-sample MR analysis, after meticulous screening, identified causal relationships between 88 metabolites and AMD. Of these, 16 metabolites showed a significant causal association. Following false discovery rate correction, 3 metabolites remained significantly associated, with androstenediol (3 beta, 17 beta) disulfate (2) exhibiting the most potent protective effect against AMD. Further exploration using Metabo Analyst 5.0 highlighted 4 metabolic pathways potentially implicated in AMD pathogenesis. This pioneering MR study has unraveled the causal connections between plasma metabolites and AMD. It identified several metabolites with a causal impact on AMD, with 3 maintaining significance after FDR correction. These insights offer robust causal evidence for future clinical applications and underscore the potential of these metabolites as clinical biomarkers in AMD screening, treatment, and prevention strategies.
Evaluation of inflammatory hyperreflective foci and plasma EPA as diagnostic and predictive markers for age-related macular degeneration

Zhongqi Wan,Yan Wu,Tianyi Shen,Chengyu Hu,Ruoyi Lin,Chengda Ren,Donghui Yu,Tingting Li,Meijiang Zhu,Wenting Cai,Jing Yu

DOI: https://doi.org/10.3389/fnins.2024.1401101

IF: 4.3

2024-10-11

Frontiers in Neuroscience

Abstract:Objectives: To detect the plasma polyunsaturated fatty acids (PUFAs) concentrations in age-related macular degeneration (AMD) patients and healthy controls. Additionally, advanced studies were conducted to investigate the relationship between PUFAs concentrations and ophthalmological characteristics, including hyperreflective foci (HRF), visual acuity, and anti-vascular endothelial growth factor (anti-VEGF) response in patients with AMD. Methods: This prospective, single-site study recruited a total of 315 participants, consisting of 105 individuals with dry AMD (early-stage AMD group), 105 individuals with neovascular AMD (late-stage AMD group), and 105 elderly individuals without any fundus diseases (healthy controls). The levels of omega-3 and omega-6 PUFAs in plasma were detected using gas chromatography. Retinal thickness, choroidal thickness, and macular volume were quantified using optical coherence tomography angiography (OCTA) scan with a 6 × 6 mm macular area, and the amounts of HRF were analyzed with OCTA scanning data. Results: Compared to the control group, AMD patients exhibited significantly lower plasma concentrations of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and alpha linolenic acid. HRF were observed in various retinal layers of AMD patients, particularly those with late-stage AMD. The correlation coefficient matrix and multiple linear regression models demonstrated that HRF played a crucial role in best corrected visual acuity for both early ( p < 0.001) and late-stage AMD patients ( p = 0.006), while EPA had an inverse effect on the logarithm of the minimum angle of resolution (logMAR) value in patients with early-stage AMD ( p < 0.001). As compared to patients with good responses to anti-VEGF therapy, those with poor responses had significantly lower baseline logMAR ( p < 0.001), central retina thickness ( p = 0.002), macular volume ( p = 0.027), HRF ( p = 0.024), and plasma EPA ( p < 0.001). This study used a ROC curve analysis to identify the combination of HRF and EPA as a potential biomarker for predicting the response to anti-VEGF treatment in late-stage AMD patients, with an area under the curve (AUC) value of 0.775. Conclusions: Reduced plasma EPA was detected in AMD cases and the lower EPA concentration was related to poorer visual acuity. Additionally, the quantity of HRF combined with concentration of plasma EPA may serve as the prognostic indicator for predicting the effect of anti-VEGF treatment in late-stage AMD patients.

neurosciences
Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks

Aaron M Newman,Natasha B Gallo,Lisa S Hancox,Norma J Miller,Carolyn M Radeke,Michelle A Maloney,James B Cooper,Gregory S Hageman,Don H Anderson,Lincoln V Johnson,Monte J Radeke

DOI: https://doi.org/10.1186/gm315

IF: 15.266

2012-01-01

Genome Medicine

Abstract:BackgroundAge-related macular degeneration (AMD) is a leading cause of blindness that affects the central region of the retinal pigmented epithelium (RPE), choroid, and neural retina. Initially characterized by an accumulation of sub-RPE deposits, AMD leads to progressive retinal degeneration, and in advanced cases, irreversible vision loss. Although genetic analysis, animal models, and cell culture systems have yielded important insights into AMD, the molecular pathways underlying AMD's onset and progression remain poorly delineated. We sought to better understand the molecular underpinnings of this devastating disease by performing the first comparative transcriptome analysis of AMD and normal human donor eyes.MethodsRPE-choroid and retina tissue samples were obtained from a common cohort of 31 normal, 26 AMD, and 11 potential pre-AMD human donor eyes. Transcriptome profiles were generated for macular and extramacular regions, and statistical and bioinformatic methods were employed to identify disease-associated gene signatures and functionally enriched protein association networks. Selected genes of high significance were validated using an independent donor cohort.ResultsWe identified over 50 annotated genes enriched in cell-mediated immune responses that are globally over-expressed in RPE-choroid AMD phenotypes. Using a machine learning model and a second donor cohort, we show that the top 20 global genes are predictive of AMD clinical diagnosis. We also discovered functionally enriched gene sets in the RPE-choroid that delineate the advanced AMD phenotypes, neovascular AMD and geographic atrophy. Moreover, we identified a graded increase of transcript levels in the retina related to wound response, complement cascade, and neurogenesis that strongly correlates with decreased levels of phototransduction transcripts and increased AMD severity. Based on our findings, we assembled protein-protein interactomes that highlight functional networks likely to be involved in AMD pathogenesis.ConclusionsWe discovered new global biomarkers and gene expression signatures of AMD. These results are consistent with a model whereby cell-based inflammatory responses represent a central feature of AMD etiology, and depending on genetics, environment, or stochastic factors, may give rise to the advanced AMD phenotypes characterized by angiogenesis and/or cell death. Genes regulating these immunological activities, along with numerous other genes identified here, represent promising new targets for AMD-directed therapeutics and diagnostics.Please see related commentary: http://www.biomedcentral.com/1741-7015/10/21/abstract

genetics & heredity
Metabolomic-derived endotypes of age-related macular degeneration (AMD): a step towards identification of disease subgroups

Kevin Mendez,Ines Lains,Rachel S. Kelly,João Gil,Rufino Silva,John Miller,Demetrios G. Vavvas,Ivana Kim,Joan Miller,Liming Liang,Jessica A. Lasky-Su,Deeba Husain

DOI: https://doi.org/10.1038/s41598-024-59045-z

IF: 4.6

2024-05-29

Scientific Reports

Abstract:Age-related macular degeneration (AMD) is a leading cause of blindness worldwide, with a complex pathophysiology and phenotypic diversity. Here, we apply Similarity Network Fusion (SNF) to cluster AMD patients into putative metabolomics-derived endotypes. Using a discovery cohort of 163 AMD patients from Boston, US, and a validation cohort of 214 patients from Coimbra, Portugal, we identified four distinct metabolomics-derived endotypes with varying retinal structural and functional characteristics, confirmed across both cohorts. Patients clustered into Endotype 1 exhibited a milder form of AMD and were characterized by low levels of amino acids in specific metabolic pathways. Meanwhile, patients clustered into both Endotype 3 and 4 were associated with more severe AMD and exhibited low levels of fatty acid metabolites and elevated levels of sphingomyelins and fatty acid metabolites, respectively. These preliminary findings indicate that metabolomics-derived endotyping may offer a refined strategy for categorizing AMD patients based on their specific pathophysiological underpinnings, rather than relying solely on traditional observational clinical indicators.

multidisciplinary sciences
Untargeted Metabolomic Study of Patients with Wet Age-Related Macular Degeneration in Aqueous Humor

Qingquan Wei,Xianghong Tu,Qinghua Qiu,Li Wang

DOI: https://doi.org/10.2147/cia.s475920

IF: 3.829

2024-09-27

Clinical Interventions in Aging

Abstract:Qingquan Wei, Xianghong Tu, Qinghua Qiu, Li Wang Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China Correspondence: Qinghua Qiu; Li Wang, Department of Ophthalmology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, 1111 Xianxia West Road, Shanghai, 200336, People's Republic of China, Email ; Purpose: The objective of this study was to ascertain metabolic biomarkers and investigate the metabolic alterations associated with aqueous humor (AH) in wet age-related macular degeneration (AMD). Methods: AH samples were collected from a total of 20 participants, including 10 individuals diagnosed with wet AMD and 10 individuals undergoing cataract surgery, serving as the control group. Metabolomics analysis was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify and quantify metabolites. Results: A total of 155 metabolites were identified in the AH samples. Among them, 10 metabolites emerged as potential biomarkers capable of differentiating patients with wet AMD from the control group. In the AH of wet AMD patients, there was increased expression of Cardiolipin (CL) (72:5), Diglyceride (DG) (18:3_18:2), DG (36:5e) and Triglyceride (TG) (24:7), while the expression of Ceramides (Cer) (d32:0), Cer (d34:0), Cer (d36:0), Monogalactosyldiacylglycerol (MGDG) (16:1_18:3), Sphingosine (SPH) (d18:0) and TG (16:0_10:4_16:0) was down regulated. Conclusion: Through metabolomics analysis of AH, this study successfully uncovered valuable metabolic biomarkers linked to wet AMD. These findings contribute to a more comprehensive understanding of the pathogenesis of wet AMD and offer potential avenues for the development of innovative treatment strategies for this condition. Keywords: metabolomic, wet age-related macular degeneration, aqueous humor Age-related macular degeneration (AMD) is a common cause of irreversible vision loss in individuals over the age of 50 and constitutes a significant concern in global public health. 1,2 AMD can be clinically classified into two forms: dry AMD and wet AMD. Wet AMD, accounting for 90% of blindness cases caused by AMD, is characterized by choroidal neovascularization (CNV). 3,4 Although the diagnosis of wet AMD is conclusive, there is still controversy surrounding the etiology and pathophysiological mechanisms of the condition. Metabolomics is a research field involving the identification and quantification of small molecules (metabolites) in biological samples and has been utilized to study metabolic alterations associated with various diseases, offering insights into their underlying mechanisms. 5,6 Metabolomic analysis of aqueous humor (AH) has exhibited potential in revealing metabolic changes related to eye diseases. 7,8 Studies have indicated that myopic patients have significantly different metabolic profiles in AH compared to healthy controls. 9 Specifically, increased concentrations of 27 important metabolites were found in myopic patients. 10 These metabolites may provide valuable information about metabolic changes that occur in the eye during the development and progression of myopia. In glaucoma—a complex neurodegenerative disease affecting the optic nerve-metabolomic analysis of AH has revealed dysregulation of metabolites related to osmoprotection, neuroprotection, and amino acid metabolism. 11 These findings suggest that metabolomics might play a role in understanding the pathophysiology of glaucoma and in identifying biomarkers for disease progression. Additionally, in diabetic retinopathy (DR), a common complication of diabetes affecting the retina, metabolomics research on AH has identified differential metabolites. 12 These metabolites might be associated with the metabolic dysregulation and vascular dysfunction observed in DR. However, the application of metabolomics in investigating wet AMD remains limited, and further research is needed to elucidate specific metabolic changes associated with this condition. Therefore, the goal of this study is to perform a comparative analysis between wet AMD patients and a control group to identify unique metabolic alterations. Furthermore, the study aims to identify potential biomarkers among these differentially regulated metabolites, which could help to better understand the pathophysiology of wet AMD and aid in the development of diagnostic and therapeutic strategies. The study enrolled 20 subjects from December 1, 2021, to March 1, 2023. All study protocols adhered to the ethical principles outlined in the Declaration of Helsinki. The institutional Research Ethics Committee of the Tong Ren Hospital affiliated with the Shanghai J -Abstract Truncated-

geriatrics & gerontology,gerontology
Metastatic Disease of the Hip: Evaluation and Treatment

A. T. Berman,F. U. Hermantin,S. Horowitz

DOI: https://doi.org/10.5435/00124635-199703000-00003

IF: 4

1997-03-01

Journal of the American Academy of Orthopaedic Surgeons

Abstract:&NA; Lesions in the area of the hip secondary to metastatic disease present challenging problems for the orthopaedic surgeon. With the advent of improved medical therapies for many types of cancer have come not only an increase in life expectancy but also an increased likelihood that symptomatic metastatic bone lesions will appear. Advances in internal fixation have enabled the orthopaedic surgeon to provide an increased level of comfort and mobility to many patients with metastatic disease.
Metabolomic Profiling of Aqueous Humor and Plasma in Primary Open Angle Glaucoma Patients Points Towards Novel Diagnostic and Therapeutic Strategy

Yizhen Tang,Yiqiong Pan,Yuhong Chen,Xiangmei Kong,Junyi Chen,Hengli Zhang,Guangxian Tang,Jihong Wu,Xinghuai Sun

DOI: https://doi.org/10.3389/fphar.2021.621146

IF: 5.6

2021-04-14

Frontiers in Pharmacology

Abstract:Glaucoma is the second leading cause of blindness globally characterized by progressive loss of retinal ganglion cells (RGCs) and irreversible visual deficiency. As the most common type of glaucoma, primary open angle glaucoma (POAG) is currently an unmet medical need with limited therapy by lowering intraocular pressure (IOP). However, some patients continue to progress even though their IOP are controlled. Although early diagnosis and prompt treatment are crucial in preventing irreversible visual impairment, there are currently no biomarkers for screening POAG. Metabolomics has the advantages of illustrating the final downstream products of the genome and establishing the closest link to the phenotype. So far, there is no study investigating the metabolomic profiles in both aqueous humor and plasma of POAG patients. Therefore, to explore diagnostic biomarkers, unveil underlying pathophysiology and potential therapeutic strategies, a widely targeted metabolomic approach was applied using ultrahigh-resolution mass spectrometry with C18 liquid chromatography to characterize the metabolomic profiles in both aqueous humor and plasma of 28 POAG patients and 25 controls in our study. Partial least squares-discriminant analysis (PLS-DA) was performed to determine differentially expressed metabolites (DEMs) between POAG and age-matched controls. The area under the receiver operating characteristic curve (AUC) was calculated to assess the prediction accuracy of the DEMs. The correlation of DEMs with the clinical parameters was determined by Pearson correlation, and the metabolic pathways were analyzed using MetaboAnalyst 4.0. PLS-DA significantly separated POAG from controls with 22 DEMs in the aqueous humor and 11 DEMs in the plasma. Additionally, univariate ROC analysis and correlation analysis with clinical parameters revealed cyclic AMP (AUC = 0.87), 2-methylbenzoic acid (AUC = 0.75), 3′-sialyllactose (AUC = 0.73) in the aqueous humor and N-lac-phe (AUC = 0.76) in the plasma as potential biomarkers for POAG. Moreover, the metabolic profiles pointed towards the alteration in the purine metabolism pathway. In conclusion, the study identified potential and novel biomarkers for POAG by crosslinking the metabolomic profiles in aqueous humor and plasma and correlating with the clinical parameters. These findings have important clinical implications given that no biomarkers are currently available for glaucoma in the clinic, and the study provided new insights in exploring diagnostic biomarkers and potential therapeutic strategies of POAG by targeting metabolic pathways.

pharmacology & pharmacy

The retention and elimination of fluorine in bones.

Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls And Predict Early Alzheimer'S Disease Via Untargeted Lipidomics Analysis

Largescale Multicenter Study of a Serum Metabolite Biomarker Panel for the Diagnosis of Breast Cancer

Metabolomics in Age-Related Macular Degeneration: A Systematic Review

Untargeted Metabolomics for Uncovering Plasma Biological Markers of Wet Age-Related Macular Degeneration.

Alterations in Faecal and Serum Metabolic Profiles in Patients with Neovascular Age-Related Macular Degeneration.

Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration

Olink Profiling of Aqueous Humor Identifies Novel Biomarkers for Wet Age-Related Macular Degeneration.

Multiomic Screening Unravels the Immunometabolic Signatures and Drug Targets of Age-Related Macular Degeneration

Choroidal biomarkers in age-related macular degeneration

Transfer of spectral weight in an exactly solvable model of strongly correlated electrons in infinite dimensions.

A Collaborative Approach to Teaching Medical Students how to Screen, Intervene, and Treat Substance Use Disorders

Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopia

A proteogenomic signature of age-related macular degeneration in blood

Causal influence of plasma metabolites on age-related macular degeneration: A Mendelian randomization study

Evaluation of inflammatory hyperreflective foci and plasma EPA as diagnostic and predictive markers for age-related macular degeneration

Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks

Metabolomic-derived endotypes of age-related macular degeneration (AMD): a step towards identification of disease subgroups

Untargeted Metabolomic Study of Patients with Wet Age-Related Macular Degeneration in Aqueous Humor

Metastatic Disease of the Hip: Evaluation and Treatment

Metabolomic Profiling of Aqueous Humor and Plasma in Primary Open Angle Glaucoma Patients Points Towards Novel Diagnostic and Therapeutic Strategy